This page, Massachusetts COVID-19 Vaccine Program (MCVP) Overview, is part of
This page, Massachusetts COVID-19 Vaccine Program (MCVP) Overview, is offered by

Massachusetts COVID-19 Vaccine Program (MCVP) Overview

The Massachusetts Department of Public Health (DPH) Immunization Division is working with the Centers for Disease Control (CDC) to distribute the COVID-19 vaccine.

The information on this page will assist you in your vaccination efforts throughout the pandemic. Below are updates and resources for the Massachusetts COVID-19 Vaccine Program (MCVP).

Table of Contents

Who can administer the COVID-19 vaccine?

This COVID-19 Vaccinators chart (updated March 30, 2021) lists the different groups of individuals who can possess and administer COVID-19 vaccines.

Eligibility to receive COVID-19 vaccine supply

All providers participating in the Massachusetts COVID-19 Vaccine Program (MCVP) are required to sign an MCVP Agreement to receive delivery of any COVID-19 vaccine.

  • Providers must be registered with the Massachusetts Immunization Information System (MIIS), in order to submit immunization administration data.
  • Providers registered with the MIIS all received the MCVP Agreement. New sites that register with the MIIS will receive the Agreement automatically. If you have not received the Agreement, contact the DPH Vaccine Unit at DPH-Vaccine-Management@massmail.state.ma.us. The MCVP Agreement must be completed in order to receive vaccine.
  • Providers must complete the onboarding process with the MIIS User Support Team to ensure that immunization data are being sent to the MIIS registry.

Additional resources:

Storage and handling

COVID-19 Vaccine Storage & Handling and Administration Training

For more vaccine storage and handling information please consult: CDC Storage and Handling Toolkit (COVID-19 Addendum Updated 2/12/21).

Routine vaccination during COVID

Routine vaccination is essential to protecting our communities against vaccine preventable diseases. CDC and DPH recommend that routine vaccinations are maintained throughout the COVID-19 pandemic. CDC recommends that provider offices identify children due for vaccination and schedule appointments starting with newborns and children up to 24 months, young children, and adolescents. For more information on immunization services during the COVID-19 Pandemic visit www.cdc.gov/vaccines/pandemic-guidance

FDA Emergency Use Authorization (EUA)

Johnson & Johnson/Janssen COVID-19 Vaccine

Pfizer-BioNTech COVID-19 Vaccine

Moderna COVID-19 Vaccine

Materials to Support Moderna EUA Changes – April 2021

With the FDA’s EUA revisions announced April 1, the Moderna vaccine will be available in two different vials by early May: the current Maximum 11 dose vial and a new Maximum 15 dose vial. CDC resources:

EUA Fact Sheets

Available in multiple languages, published by FDA.gov:

Learn more about EUA on FDA.gov: COVID-19 Vaccines

Feedback